[Retracted] Influence Factors and Predictive Models for the Outcome of Patients with Ischemic Stroke after Intravenous Thrombolysis: A Multicenter Retrospective Cohort Study

Table 4

Univariate analysis of early neurological recovery after IVT of patients with ischemic stroke.

No.	Factors	All ()	Group 1 ()	Group 0 ()
1	Gender (male)	337 (56.7%)	171 (53.4%)	166 (60.6%)	3.071	0.080
2	Ages (year)				3.873	<0.001
3	BMI (kg/m^2)				-2.701	0.007
4	BNIHSS (score)	5 (2.75, 12.00)	6 (3, 13)	4 (2, 11)	-4.939	<0.001
5	Smoking (yes)	173 (29.1%)	94 (29.4%)	79 (28.8%)	0.021	0.885
6	SecondThrombolysis (yes)	13 (2.2%)	4 (1.3%)	9 (3.3%)	2.855	0.091
7	Hypertension (yes)	409 (68.9%)	232 (72.5%)	177 (64.6%)	4.297	0.038
8	preAF (yes)	95 (16.0%)	60 (18.8%)	35 (12.8%)	3.924	0.048
9	preIHD (yes)	36 (6.1%)	19 (5.9%)	17 (6.2%)	0.018	0.892
10	NewAF (yes)	28 (4.7%)	11 (3.4%)	17 (6.2%)	2.516	0.113
11	DM (yes)	89 (15.0%)	57 (17.8%)	32 (11.7%)	4.360	0.037
12	HL (yes)	18 (3.0%)	7 (2.2%)	11 (4.0%)	1.677	0.195
13	CHD (yes)	47 (7.9%)	28 (8.8%)	19 (6.9%)	0.668	0.414
14	CHF (yes)	17 (2.9%)	7 (2.2%)	10 (3.6%)	1.135	0.287
15	PreStrokeHistory (yes)	87 (14.6%)	50 (15.6%)	37 (13.5%)	0.531	0.466
16	CHDHistory (yes)	3 (0.5%)	1 (0.3%)	2 (0.7%)
17	HHcy (yes)	33 (5.6%)	21 (6.6%)	12 (4.4%)	1.341	0.247
18	Aspirin (yes)	77 (13.0%)	38 (11.9%)	39 (14.2%)	0.728	0.394
19	Clopidogrel (yes)	17 (2.9%)	11 (3.4%)	6 (2.2%)	0.827	0.363
20	Warfarin (yes)	8 (1.3%)	5 (1.6%)	3 (1.1%)
21	Atorvastatin (yes)	27 (4.5%)	18 (5.6%)	9 (3.3%)	1.863	0.172
22	Rosuvastatin (yes)	25 (4.2%)	12 (3.8%)	13 (4.7%)	0.362	0.547
23	PreSBP (mmHg)				2.003	0.046
24	PreDBP (mmHg)				0.015	0.988
25	Hb (g/L)				-1.395	0.164
26	RBC (◊10^12/L)	4.58 (4.26, 4.93)	4.54 (4.14, 4.89)	4.65 (4.35, 4.98)	-2.717	0.007
27	WBC (◊10^9/L)				1.629	0.104
28	N (%)				2.462	0.014
29	PLT (◊10^9/L)				0.198	0.843
30	K+ (mmol/L)				-0.339	0.735
31	Na+ (mmol/L)				-0.999	0.318
32	UN (mmol/L)	6.03 (4.90, 7.20)	6.10 (4.93, 7.47)	6.00 (4.90, 7.00)	-0.924	0.355
33	Cr (μmol/L)				1.358	0.175
34	PT (s)				-0.953	0.341
35	APTT (s)				-2.157	0.031
36	INR				-0.948	0.343
37	Fg (g/L)	3.38 (2.69, 4.03)	3.46 (2.73, 4.11)	3.30 (2.68, 3.91)	-1.681	0.093
38	Time (min)				2.541	0.011
39	Drug (u-PA)	49 (8.2%)	36 (11.3%)	13 (4.7%)	8.254	0.004

Note: (1) Group 1 is the poor early neurological function recovery group; group 0 is the good early neurological function recovery group; (2) represents the value calculated by Fisher’s exact probability method.